Canadian Cancer Society reports draw attention to the disease’s financial burden on patients, which includes the toll of ...

A research team affiliated with UNIST has unveiled an innovative technology to eliminate drug-resistant cancer cells using ...

A new computational tool could help researchers identify promising drug combinations for treating cancer, according to a new ...

A national study seeking more effective treatment for deadly metaplastic breast cancer has identified two inhibitor drugs with the potential to interrupt disease progression.

The FDA approved Datroway to treat metastatic or unresectable HR+/HER2- breast cancer in people who have tried standard chemo ...

Visakhapatnam: Drug repurposing is emerging as a promising strategy for tackling drug-resistant and metastatic cancers.

New research from Emory University and international organizations could be a breakthrough in treating childhood brain cancer ...

Brain cancer is the second-leading cause of death in children in the developed world. For the children who survive, standard ...

Scientists have developed retriever, a computational tool that extracts disease-specific drug response signatures to predict the best combinations for cancer treatment.

Separately, Rakovina Therapeutics expects to receive the first synthesized drug candidates from its second AI-driven drug ...

Mayo Clinic, Mount Sinai and Huntsman Cancer Insitute are delivering services from chemotherapy to imaging in cancer patients ...

Dr. Marwan G. Fakih discussed the FDA approval of Lumakras with Vectibix for third-line treatment of KRAS G12C-mutated ...